Department of Pharmacognosy, Faculty of Pharmacy, University of Pécs, H-7624, Rókus u. 2, Pécs, Hungary.
Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, H-7624, Rókus u. 2, Pécs, Hungary.
BMC Complement Med Ther. 2022 Apr 30;22(1):119. doi: 10.1186/s12906-022-03604-2.
Interstitial cystitis (IC) has a chronic chemical irritation and inflammation of non-bacterial origin in the bladder wall leading to various severe symptoms. There is evidence that chronic inflammation is significantly associated with abnormal urothelial barrier function, epithelial dysfunction. This is the underlying cause of urothelial apoptosis and sterile inflammation.
The anti-inflammatory effects of lavender and eucalyptus essential oils (EOs) and their main components (linalool and eucalyptol) were investigated in the T24 human bladder epithelial cell line on TNFα stimulated inflammation, at 3 types of treatment schedule. The mRNA of pro-inflammatory cytokines (IL-1β, IL-6, IL-8) were measured by Real Time PCR. Human IL-8 ELISA measurement was performed as well at 3 types of treatment schedule. The effects of lavender and eucalyptus EOs and their main components were compared to the response to NFκB inhibitor ACHP (2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-(4-piperidinyl)-3-pyridinecarbonitrile).
There is no significant difference statistically, but measurements show that lavender EOs are more effective than eucalyptus EO. Long time treatment (24 h) of both lavender EO and linalool showed higher effect in decreasing pro-inflammatory cytokine mRNA expression than ACHP inhibitor following TNFα pre-treatment. Moreover, both lavender EOs were found to be significantly more effective in decreasing IL-8 secretion of T24 cells after TNFα pre-treatment compared to the ACHP NFκB-inhibitor.
The lavender EOs may be suitable for use as an adjunct to intravesical therapy of IC. Their anti-inflammatory effect could well complement glycosaminoglycan-regenerative therapy in the urinary bladder after appropriate pharmaceutical formulation.
间质性膀胱炎(IC)是一种非细菌性起源的膀胱壁慢性化学刺激和炎症,导致各种严重症状。有证据表明,慢性炎症与异常尿路上皮屏障功能、上皮功能障碍密切相关。这是尿路上皮细胞凋亡和无菌性炎症的根本原因。
在 TNFα 刺激的炎症条件下,我们研究了薰衣草和桉树精油(EOs)及其主要成分(芳樟醇和桉油醇)在 T24 人膀胱上皮细胞系中的抗炎作用,并采用了 3 种不同的治疗方案。通过实时 PCR 测量促炎细胞因子(IL-1β、IL-6、IL-8)的 mRNA。同时,还进行了 3 种不同治疗方案下的人 IL-8 ELISA 测量。将薰衣草和桉树 EOs 及其主要成分的作用与 NFκB 抑制剂 ACHP(2-氨基-6-[2-(环丙基甲氧基)-6-羟基苯基]-4-(4-哌啶基)-3-吡啶甲腈)的反应进行了比较。
虽然没有统计学上的显著差异,但测量结果表明薰衣草 EO 比桉树 EO 更有效。与 TNFα 预处理后 NFκB 抑制剂 ACHP 相比,薰衣草 EO 和芳樟醇的长时间(24 小时)治疗均显示出更高的降低促炎细胞因子 mRNA 表达的效果。此外,与 NFκB 抑制剂 ACHP 相比,薰衣草 EOs 在 TNFα 预处理后 T24 细胞 IL-8 分泌的降低方面更为有效。
薰衣草 EOs 可作为 IC 膀胱内治疗的辅助药物。在适当的药物制剂后,它们的抗炎作用可能很好地补充膀胱中糖胺聚糖再生治疗。